Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-003793
Filing Date
2025-06-04
Accepted
2025-06-04 16:03:14
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3307
  Complete submission text file 0001950047-25-003793.txt   4818
Mailing Address C/O ALEXION PHARMACEUTICALS, INC 352 KNOTTER DRIVE CHESHIRE CT 06410
Business Address
Hallal David (Reporting) CIK: 0001457477 (see all company filings)

Type: 144

Mailing Address 321 ARSENAL STREET BLDG 312, FLOOR 3, SUITE 301 WATERTOWN MA 02472
Business Address 321 ARSENAL STREET BLDG 312, FLOOR 3, SUITE 301 WATERTOWN MA 02472 857-204-4583
iTeos Therapeutics, Inc. (Subject) CIK: 0001808865 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39401 | Film No.: 251023068
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)